Gain-of-function mutations in RET lead to the development of specific human cancers and have been associated with the regulation of MMPs, including MMP2 and MMP9, which are thought to drive metastasis (Kato et al, 1998; Asai et al, 1999). The gene discussed is MMP2; the disease is cancer.